文献速递肝胆胰外科

机器人与腹腔镜保留脾脏远端胰腺切除术的两方法基准值建立

Benchmarking of robotic and laparoscopic spleen-preserving distal pancreatectomy by using two different methods.
PubMed 文献 · Br J Surg · 2022-01-01

该多中心研究纳入2006—2019年951例腹腔镜和279例机器人辅助保留脾脏远端胰腺切除术患者,采用ABC法和最佳中心最佳患者法计算10项结局的基准值,两种方法所得基准值不同,应分别解读和应用。

要点

  • 腹腔镜与机器人辅助保脾远胰切除的基准值因方法而异。
  • ABC法基准值更严格,最佳中心最佳患者法更宽松。
  • 两种方法得出的基准值应区别解读和临床应用。

核心结论

  • 两种微创保留脾脏远端胰腺切除术的基准计算方法产生不同数值,应分别解读和应用。

研究设计与样本

  • 多中心数据库研究,纳入2006—2019年951例腹腔镜(77.3%)和279例机器人辅助(22.7%)保脾远端胰腺切除术患者。

主要发现

  • ABC法下腹腔镜与机器人辅助的手术时间分别为150和207分钟,出血量55和100毫升,中转率3.5%和1.7%。
  • ABC法下保脾失败率0和1.7%,总体并发症27.3%和34.0%,严重并发症5.1%和3.3%。
  • ABC法下胰瘘B/C级3.6%和7.1%,住院5和6天,再入院2.9%和5.4%,90天死亡率均为0。
  • 最佳中心最佳患者法下腹腔镜与机器人辅助的手术时间分别为254和262.5分钟,出血量150和195毫升,中转率5.8%和8.2%。
  • 最佳中心最佳患者法下保脾失败率29.9%和27.3%,总体并发症62.7%和55.7%,严重并发症20.4%和14%。

关键数值与推荐

  • ABC法基准值:腹腔镜手术时间150分钟、出血55毫升、中转3.5%、保脾失败0%、总体并发症27.3%、严重并发症5.1%、胰瘘B/C级3.6%、住院5天、再入院2.9%、90天死亡0%。
  • ABC法基准值:机器人辅助手术时间207分钟、出血100毫升、中转1.7%、保脾失败1.7%、总体并发症34.0%、严重并发症3.3%、胰瘘B/C级7.1%、住院6天、再入院5.4%、90天死亡0%。
  • 最佳中心最佳患者法基准值:腹腔镜手术时间254分钟、出血150毫升、中转5.8%、保脾失败29.9%、总体并发症62.7%、严重并发症20.4%、胰瘘B/C级23.8%、住院8天、再入院20%、90天死亡0%。
  • 最佳中心最佳患者法基准值:机器人辅助手术时间262.5分钟、出血195毫升、中转8.2%、保脾失败27.3%、总体并发症55.7%、严重并发症14%、胰瘘B/C级24.2%、住院8天、再入院15.1%、90天死亡0%。

临床怎么用

  • 临床可用ABC法基准值作为微创保脾远端胰腺切除术质量比较的严格参照。
  • 最佳中心最佳患者法基准值较宽松,适用于不同情境下的质量评估与改进。
  • 应用基准值时应明确所采用的方法,避免混淆解读。

局限性

  • 原文摘要未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Benchmarking is an important tool for quality comparison and improvement. However, no benchmark values are available for minimally invasive spleen-preserving distal pancreatectomy, either laparoscopically or robotically assisted. The aim of this study was to establish benchmarks for these techniques using two different methods. METHODS: Data from patients undergoing laparoscopically or robotically assisted spleen-preserving distal pancreatectomy were extracted from a multicentre database (2006-2019). Benchmarks for 10 outcomes were calculated using the Achievable Benchmark of Care (ABC) and best-patient-in-best-centre methods. RESULTS: Overall, 951 laparoscopically assisted (77.3 per cent) and 279 robotically assisted (22.7 per cent) procedures were included. Using the ABC method, the benchmarks for laparoscopically assisted and robotically assisted spleen-preserving distal pancreatectomy respectively were: 150 and 207 min for duration of operation, 55 and 100 ml for blood loss, 3.5 and 1.7 per cent for conversion, 0 and 1.7 per cent for failure to preserve the spleen, 27.3 and 34.0 per cent for overall morbidity, 5.1 and 3.3 per cent for major morbidity, 3.6 and 7.1 per cent for pancreatic fistula grade B/C, 5 and 6 days for duration of hospital stay, 2.9 and 5.4 per cent for readmissions, and 0 and 0 per cent for 90-day mortality. Best-patient-in-best-centre methodology revealed milder benchmark cut-offs for laparoscopically and robotically assisted procedures, with operating times of 254 and 262.5 min, blood loss of 150 and 195 ml, conversion rates of 5.8 and 8.2 per cent, rates of failure to salvage spleen of 29.9 and 27.3 per cent, overall morbidity rates of 62.7 and 55.7 per cent, major morbidity rates of 20.4 and 14 per cent, POPF B/C rates of 23.8 and 24.2 per cent, duration of hospital stay of 8 and 8 days, readmission rates of 20 and 15.1 per cent, and 90-day mortality rates of 0 and 0 per cent respectively. CONCLUSION: Two benchmark methods for minimally invasive distal pancreatectomy produced different values, and should be interpreted and applied differently.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. van Ramshorst TME, Giani A, Mazzola M, et al. Benchmarking of robotic and laparoscopic spleen-preserving distal pancreatectomy by using two different methods. Br J Surg. 2022. PMID: 36322465. doi:10.1093/bjs/znac352

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。